TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Patient preference for self-testing pathway
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change of Forced expiratory volume in first second (FEV1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: abundance of key SCFA-producing gut bacteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Tampa Scale of Kinesiophobia
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Vestibular Disorders Activities of Daily Life
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Serious Adverse Events Rate
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of confirmation of normoposition of the nasogastric tube
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: UPPER EXTREMITY FUNCTIONAL INDEX
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: RANGE OF MOTION
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Female Sexual Distress Scale-Revised
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sexual Quality of Life Scale-Female
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Quadriplegia Index Of Functionality-Small Form (QIF-SF)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Resting state functional connectivity of default mode network
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Body weight of both parent and kids (>14 years)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with Physiologic BPD or death
Endpoint domain: Mortality/survival
Primary endpoint: Ovulation Day Estimation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Shear Stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in transdiagnostic repetitive negative thinking
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: IOP reduction success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Patients who Complete All Visits
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Geometric mean concentration (GMC) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Malondialdehyde (MDA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Index of microcirculatory resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Circulatory outcomes
Primary endpoint: Local failure
Endpoint domain: Mortality/survival
Primary endpoint: Regional failure
Endpoint domain: Mortality/survival
Primary endpoint: Distant failure
Endpoint domain: Mortality/survival
Primary endpoint: Change in short interval intracortical inhibition (SICI) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Safety of FRuctosin
Endpoint domain: Adverse events/effects
Primary endpoint: Postoperative residual neuromuscular blockade
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change from Baseline physical abilities (balance, gait speed and lower limbs strength)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline general physical performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain degree based on visual analog scale (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adaptive Eating Behavior
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Optic nerve sheet measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Hospitalization for heart failure within 30 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in N-terminal pro b-type natriuretic peptide (NtProBNP) between randomization and D30
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Level of accordance between the ASUS HealthConnect App and the sphygmomanometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite of mortality, thromboembolic event and heart failure
Endpoint domain: Mortality/survival
Primary endpoint: Recurrent symptomatic atrial fibrillation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Sustained ROSC to hospital admission
Endpoint domain: Mortality/survival
Primary endpoint: Volume of fluid received during resuscitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Redeemed drug prescriptions
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Incidence of rapid change in sNa level within 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Movement Capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Speed test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Test Time up and Go
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of moderate and severe radiographic cerebral vasospasm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: rate of FES positivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: PME/PDE-ratio from Area Under the Curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in PME/PDE (ΔPME/PDE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Change From Baseline in LS-BMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Myocardial perfusion reserve index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of patients with mRS 0-2 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use of prescribed drugs
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Numbers of masticatory muscle pain with palpation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Numbers of supplemental muscle pain with palpation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: CR rate of EOT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change of lung nodule size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Histologic change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pathologic Tumor Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in Systolic Blood Pressure at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Diastolic Blood Pressure at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in the alpha diversity index (Shannon)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 28 day transplant free survival
Endpoint domain: Mortality/survival
Primary endpoint: MADRS score at day 42
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Muscle Quality Index (MQI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Muscle morphology
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Mental Health Quality of Life Scale (MHQoL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: PROMIS Cognitive Function v2.0 - Short Form
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: KOA Symptom Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Isokinetic Muscle Strength Testing of the Knee
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: incidence of neonatal respiratory distress syndrome (RDS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Overall nutrition knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: mucosal immunity to poliovirus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: concentration of free T3
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: concentration of free T4
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: concentration of TSH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: ASIA Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in the level of anti-citrullinated protein antibodies (ACPAs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Forced Expiratory Volume in One Second
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Overall survival 2 (OS2)
Endpoint domain: Mortality/survival
Primary endpoint: Rate of patients who decide to enroll in a substance abuse disorder clinical study
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of substance abuse disorder patients who remain in clinical trial until completion
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Recommendation to continue or discontinue vitamin supplement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percent of Time in Range (TIR 70-180 mg/dL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Patients' therapeutic alliance
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Patients' well-being
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Daily FeNO increase after occupational exposure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Daily FeNO increase after environmental exposure during commuting
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Diurnal FeNO variations during a work week after occupational exposure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Diurnal FeNO variations during a work week after environmental exposure during commuting
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Release of Growth Hormone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Rate of decline in CT defined skeletal muscle index at L3 vertebra
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Local sleep topography
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: Achievement of drug concentration targets
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in fat mass composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in fat free mass composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time taken in seconds in seeking out the leading cause of difficult CPB separation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The rate of successful diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes of blood flow in the spinal cord
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Successful selective cannulation of both coronary arteries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Q-wave myocardial infarctions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Distance between biopsy site and area of greatest malignancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Prognosis of moderate to severe head injury
Endpoint domain: Mortality/survival
Primary endpoint: Intracranial local progression-free survival time (iLPFS)
Endpoint domain: Mortality/survival
Primary endpoint: Change in Index of Microcirculatory resistance (IMR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pneumococcal vaccination uptake
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Subjective Cognitive Function
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: 12-month treatment success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Paykel Suicide Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mood and Feelings Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Help-seeking Behavior Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Katz Daily Life Activities Scale (GYA)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Quality of Life Scale (SF-12)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in physical activity (weekly steps)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Speech Recognition in Noise Performance Accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fluctuation of movement abilities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety evaluation of the study intervention
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of mild pain on mobilization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of grade 2 or higher respiratory toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical performance of catheter during insertion of device
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Clinician impression of device removal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Percent change in the relative abundance of Faecalibacterium prausnitzii and other SCFA producing bacteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Center of mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Joint moment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Local dynamic stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient Engagement-Prenatal Adequacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient Engagement-Prenatal Adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient Engagement-Postnatal adequacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Observed Negative Emotional Responses
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of Participants Who Had IBD Relapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Time to Relapse After Biologics Discontinuation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Percentage of Participants Experiencing Infection
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of first hospitalization for congestive heart failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Clinician-Administered PTSD Scale (CAPS-5) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of subacute sepsis-associated cardiac disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Parental Fever Management Scale score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Modified Glasgow Dyspepsia Severity Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: presence of spontaneous dental abscesses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Incidence of freedom from major adverse cardiovascular and cerebrovascular events (MACCE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Area Under the Plasma-Concentration Time Curve (AUCinf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Food acceptance of canteen menus
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of Eligible Subjects Who Get Enrolled in the Trial
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of Participants Who Complete the 4-weeks Assessments
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Proportion of Participants Who Complete the 12-weeks Assessments
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Longitudinal Arch Angle (LAA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: need for decortication
Endpoint domain: Adverse events/effects
Primary endpoint: Seizure frequency and severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: muscle ultrasound
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in HOMA-IR concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Physician's Global Assessment of disease severity (PGA) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Agreement in diagnosis of lung overdistension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: PSA progression free survival (PSA-PFS) at 1 year
Endpoint domain: Mortality/survival
Primary endpoint: Incidence and severity of adverse events (AEs), serious adverse events (SAEs), and immune-related adverse events (irAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Renal clearance of adavosertib from plasma (CLR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Objective Response Rate per RECIST 1.1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improved parenting skills
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Computed tomography pulmonary artery obstruction index (CT-PAOI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Accuracy rate for Diagnosis of TB
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of Participants Who Attended a Donation Appointment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Power output during maximal sprint cycling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in brain activity and connectivity through fMRI before and after treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in brain activity and connectivity through fMRI between somatotopic and non somatotopic stimulation at feet
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of subjects with Treatment-emergent AEs (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Presence of a cerebral zone with a z-score > 1.96
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Major Pathologic response (MPR) rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC ROC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hemoglobin A1c (HbA1c), %
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Patient Preference
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Alpha diversity of the microbiota
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Beta diversity of the microbiota
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Expiration variability index (EVI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Changes in subject performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Strength scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intensity/interference scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Transfused Blood Volume (mL/kg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Clearance rate of cancer lesions at 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Clearance rate of cancer lesions at 3 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes